The MDM2-p53 pathway revisited
Subhasree Nag(Texas Tech University), Ruiwen Zhang(Institute of Pharmacology)
Cited by 410
Related Papers
Targeting MDM2-p53 Interaction for Cancer Therapy: Are We There Yet?
|Current Medicinal Chemistry|2014|144
<i>In vitro</i> and <i>In vivo</i> Anticancer Activity of Novel Synthetic Makaluvamine Analogues
|Clinical Cancer Research|2009|65
Recent Advances in Validating MDM2 as a Cancer Target
|Anti-Cancer Agents in Medicinal Chemistry|2009|48
Inulanolide A as a new dual inhibitor of NFAT1-MDM2 pathway for breast cancer therapy
|Oncotarget|2016|29
Identification of lineariifolianoid A as a novel dual NFAT1 and MDM2 inhibitor for human cancer therapy
|Journal of Biomedical Research|2016|23